New Ways to Target Androgens in Prostate Cancer
June 21, 2012
Prostate cancer cells require androgens including testosterone to grow. A recent review in the British Journal of Urology International describes new classes of drugs that target androgens in novel ways, providing
alternatives to the traditional methods that frequently carry high side effects.
Continuous vs. Intermittent ADT Therapy
June 18, 2012
Dr. Myers talks about continuous versus intermittent ADT for PCa.
ScotiaBank Awareness Night Videos
June 12, 2012
CLICK ON THE BLUE TEXT BELOW, TO GO TO OUR VIDEOS
MAY 2012 Awareness Night
“Prostate Cancer Diagnostics: the past, present, and future and the PSA controversy.”
Dr. Rajiv Singal MD, FRCSC Head, Division of Urology, Toronto East General Hospital
MARCH 2012 Awareness Night
“Holistic and Herbal: two approaches to diet, nutrition, and the treatment of prostate cancer.”
Part 1
Prostate Health & Nutrition
Eileen Fauster
Talk is about actively strengthening your own immunity and adopting a health-promoting lifestyle by incorporating a healing-conducive nutrition plan.
Part Two Morwenna Given COMING SOON
January 2012 Awareness Night
VIDEO: Dr. Tony Finelli “Traditional vs Laproscopic vs Robotic- Assisted -Which type of surgery is best for you?”
Dr. Tony Finelli
MD, MSc, FRCSC
Division of Urology Minimally Invasive Surgery
Department of Surgical Oncology
Associate Professor. University of Toronto
Princess Margaret Hospital. Toronto, Canada
November 2011 Awareness Night
“Surveillance, Surgery & Radiation: Decisions, Uncertainty & Wellbeing”
Dr. Andrew Matthew,Ph.D.,
C.Psych Psychologist,
Princess Margaret Hospital, Toronto, Canada
Dr. Matthew’s research focuses on urologic cancers and involves cancer prevention, treatment decision-making, sexual rehabilitation, intimacy, quality of life, and survivorship. He shares his thoughts on coping strategies with regard to the emotional challenges of the prostate cancer journey….the pca diagnosis, making treatment decisions, lifestyle changes.
September 2011 Awareness Night
“Incontinence and Erectile Dysfunction”
Dr. Timothy Davies MD, FRCSC,
Assistant Professor, Department of Surgery,
McMaster UniversityDivision of Urology
Henderson Hospital Hamilton
July 2011 Awareness Night
“Diet, Nutrition and Lifestyle in relation to Prostate Cancer”
Dr. Vasundara Venkateswaran
There is growing evidence that, apart from the preventative benefit, diet and nutrition could play an important part in managing the progression of prostate cancer. This recognition is of particular importance to the newly-diagnosed who are considering active surveillance, to advanced prostate cancer survivors because control of cancer growth is so critical, and to regular prostate cancer survivors concerned about recurrence.
May 2011 Awareness Night
Our fourth Survivor Forum, features a panel of prostate cancer survivors
who represent a broad range of treatments and experiences.
Bill Sceviour: Chemotherapy, External Beam Radiation, Hormone Therapy
Glen Tolhurst: Brachytherapy
Mark Surchin: Laparoscopic Robotic Surgery
David Lunt: Radical Prostatectomy, Hormone Therapy, Radiation
Philip Ng: Hyperthermia, Hormone Therapy
Active Surveillance
Mark Weir: HIFU
March 2011 Awareness Night
Prostate Cancer: To the biopsy and beyond
Featuring
Dr. Roger Buckley, Medical Director, Gale and Graham Wright Prostate Centre and Chief of Urology
Dr. Denis Macdonald, Chief Pathologist and Director of Laboratories, Department of Laboratory Medicine
Dr. Irv Jacobs, Chief of Radiography Department
North York General Hospital
The Gale and Graham Wright Prostate Centre
January 2011 Awareness Night
Dr. Robert Bristow – “Personalized Medicine in Prostate Cancer”
November 2010 Awareness Night
Dr. Andrew Matthew “The Psychological Aspect of Prostate Cancer”
“A Special Tribute to Aaron Bacher” Aaron Bacher steps down after 8 1/2 Years as Chairman of “Man to Man” now “PCCN-Toronto”
June 2012 Newsletter
June 6, 2012
The June 2012 Newsletter is available by clicking here
Some of the content:
- Wake Up call Breakfast
- Dr. Uri Lindner at July 25, 2012 Scotiabank Awareness Night
- Two Dieticians speaks at March Scotiabank Awareness Night
- Dr. Singal speaks at May Scotiabank Awareness Night
- Meet Philip Ng
- PCCN Conference – Regina
- Words from Ken Hunter
- PCCN-Toronto makes donations to 3 hospitals
- On-going Projects for 2012
- The PCCN-Toronto Board of Directors (including photo)
Raduim-223 Drug Beneficial for Bone Metatasis Patients
June 6, 2012
Treatment with the investigational drug radium-223 (Alpharadin) is associated with significantly increased overall survival in patients with castration-resistant prostate cancer (CRPC), researchers reported at the American Society of Clinical Oncology 2012 annual meeting.
Cancer on the Brain – Cancer Phobia
June 5, 2012
I got a call from a friend last year. He had prostate cancer and wanted some help thinking through what to do. He had gone to his doctors for the details about his physical condition. He was calling me for help dealing with the other condition he knew he was facing — excessive fear of this dreaded disease that sometimes does more harm than good, what some have called “cancer phobia.”
Survival Better with Continuous ADT
June 4, 2012
CHICAGO—Intermittent androgen deprivation therapy (ADT) has some quality-of-life (QOL) benefits for men with metastatic prostate cancer (PCa), but overall survival times are inferior to those seen with continuous ADT, according to the findings of a 17-year study (SWOG9346) presented at the American Society for Clinical Oncology 2012 annual meeting.
Protein Marker for Aggressive Prostate Cancer
June 1, 2012
Prostate cancer protein discovered by scientists could lead to new tests and treatments
* The protein is found in aggressive forms of the cancer
* Scientist believe they can use the protein as a marker, providing a potential new target for drug treatment
Read More
Focal HIFU
June 1, 2012
It is hoped the new treatment, which involves heating only the tumours with a highly
focused ultrasound, will mean men can be treated without an overnight stay in hospital
and avoiding the distressing side effects associated with current therapies.
Read more.